Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net income (loss)	$ (16,600)	$ 889,300
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	2,100	800
Changes in allowance for doubtful accounts	2,000	5,400
Unrealized (gain) loss from marketable securities	103,400	(173,400)
Gain on sale of patents		(269,800)
Changes in operating assets and liabilities:
Accounts receivable	192,400	(45,000)
Prepaid expenses and other current assets	(261,500)	1,200
Accounts payable and accrued expenses	31,000	(60,500)
Lease liabilities	(400)
Deferred revenue	23,800	(139,200)
Net cash provided by operating activities	76,200	208,800
Cash flows from investing activities
Purchase of marketable securities		(290,500)
Purchase of hopTo common stock	(10,100)
Proceeds from sale of patents		269,800
Purchase of property and equipment		(3,400)
Net cash used by investing activities	(10,100)	(24,100)
Net change in cash	66,100	184,700
Cash and cash equivalents, beginning of the period	4,755,300	4,375,300
Cash and cash equivalents, end of the period	$ 4,821,400	$ 4,560,000